A report about perceptions of the Innovation Agency has been published following an independent survey.
The research was commissioned by NHS England and NHS Improvement, and the Office for Life Sciences (OLS) to explore and evaluate the views of stakeholders of all Academic Health Science Networks (AHSNs).
It was carried out by Savanta ComRes with input from AHSNs and commissioners. The company developed and ran an online survey and telephone interviews during the summer and autumn of 2019. Those taking part were stakeholders in health and social care, private and voluntary sectors, national and local governance bodies, research and academia, patient groups and the general public.
Topics covered included familiarity with and perceptions of AHSNs; evaluations of AHSNs’ communications, services, support, work programmes and cross-regional working; and perceived opportunities and challenges for AHSNs in the future.
Innovation Agency Chief Executive Dr Liz Mear said: “I would like to thank everyone who took part in the survey as this gives us valuable feedback on which to plan our future work. I am delighted that the results were very positive, which is testimony to our fantastic staff and a strong team-working approach.”
Key findings about the Innovation Agency:
- An open-door policy and networking events are helping to establish the Innovation Agency as a valuable and collaborative organisation that involves a wide range of parties and facilitates network building.
- A key strength of this AHSN is its marketing and visibility, driven in part by memorable events and presentations of the impactful work being done, as well as the signposting of stakeholders to useful opportunities and supporting them with proposals.
- Stakeholders are keen to see this AHSN build on its successes by utilising its strengths in the context of work being done by other AHSNs, as well as connecting them to opportunities across the country.
News and blogs >
Collaborating for medicines safety Read more
A programme to reduce the avoidable harm caused by opioids is now on a firm footing in the North West Coast.
Launch of new lipid management pathway Read more
Clinicians in Cheshire and Merseyside have collaborated on a new lipid management pathway aimed at improving outcomes for people with cardiovascular disease (CVD).
Mental health innovators to benefit from £20m programme Read more
Health Innovation North West Coast is backing a programme to support innovators working at the forefront of mental health therapeutics
“Real world validation” being validated by the academic community Read more
A recent report demonstrates the acceptance of “real world” data from health care settings and the impact on patients being used to inform academic research.
